SomaLogic appoints former Foundation Medicine chief as executive chair
- SomaLogic (NASDAQ:SLGC) said Monday it appointed board member and biotech veteran Troy Cox as executive chair of its board, effective immediately.
- Chuck Lillis, the company's current chair, continue to serve as a board member.
- Cox has over 30 years' experience in life sciences and biopharmaceuticals, who'd earlier served as CEO of Foundation Medicine.